Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2022 | Escient Pharmaceuticals | $120.0M Series C | Abingworth, Forge Life Science Partners, NEA | 5AM Ventures, Access Biotechnology, Atlas Venture, Carol Gallagher, Robert Garland, Nextech Invest, OrbiMed, Osage University Partners, Sanofi Ventures, The Column Group, Altitude Life Science Ventures, Avego Bioscience Capital, Cowen Healthcare Investments, PFM Health Sciences, Redmile Group |
| Jul 19, 2022 | Alleaves | $40.0M Series A | The Eleven Fund | — |